Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Organisation › Details

Creoptix AG

Creoptix is a private company headquartered in Wädenswil, near Zurich, Switzerland, and with US offices in the Boston area. Creoptix focuses on next-generation bioanalytical instruments for drug discovery and development as well as academic research. Based on its proprietary sensor and microfluidics technology, the Creoptix WAVE systems provide exceptionally high sensitivity and resolution in characterizing real-time interactions between small molecules, peptides, proteins and other molecules and even in crude samples like undiluted serum or plasma. *


Period Start 2017-02-06 existent
Products Industry Creoptix WAVE system
  Industry 2 waveguide interferometry technology
Person Person Raquet, Line Stigen (Creoptix 202001– CEO before Mettler-Toledo + Qiagen)
  Street 76 Zugerstr.
  City 8820 Wädenswil ZH
  Tel +41-44-533-2660
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich).
Record changed: 2021-01-12


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Creoptix AG

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top